Article
Novel ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus.
Antimicrobial agents and chemotherapy - 1 Jul 2002
Piddock Laura J V, Jin Yu Fang, Webber Mark A, Everett Martin J
Abstract excerpt
A ciprofloxacin-resistant, nalidixic acid-susceptible mutant of Staphylococcus aureus (F145) contained no mutations within gyrA, gyrB, grlA, and grlB or within norA or its promoter region. MICs and accumulation studies suggest the role of a novel multidrug efflux pump.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
